Cabazitaxel
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06772 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | female breast carcinoma | KG + DL |
| 2 | sickle cell-hemoglobin E disease syndrome | KG + DL |
| 3 | sickle cell-hemoglobin d disease syndrome | KG + DL |
| 4 | hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | KG + DL |
| 5 | sickle cell-hemoglobin c disease syndrome | KG + DL |
| 6 | sickle cell-beta-thalassemia disease syndrome | KG + DL |
| 7 | HIV infectious disease | KG + DL |
| 8 | hyperthyroidism | KG + DL |
| 9 | neuroblastoma | KG + DL |
| 10 | rheumatoid arthritis | KG + DL |
| 11 | collagenopathy | KG + DL |
| 12 | lymphocytic hypereosinophilic syndrome | KG + DL |
| 13 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 14 | myeloid leukemia | KG + DL |
| 15 | feline acquired immunodeficiency syndrome | KG + DL |
| 16 | simian immunodeficiency virus infection | KG + DL |
| 17 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 18 | ganglioneuroblastoma (disease) | KG + DL |
| 19 | retroperitoneal neoplasm | KG + DL |
| 20 | vertebral anomalies and variable endocrine and T-cell dysfunction | KG + DL |
| 21 | nipple carcinoma | KG + DL |
| 22 | Graves disease | KG + DL |
| 23 | hypereosinophilic syndrome | KG + DL |
| 24 | sickle cell disease and related diseases | KG + DL |
| 25 | estrogen-receptor negative breast cancer | KG + DL |
| 26 | hormone-resistant breast carcinoma | KG + DL |
| 27 | Ehrlich tumor carcinoma | KG + DL |
| 28 | estrogen-receptor positive breast cancer | KG + DL |
| 29 | bilateral breast carcinoma | KG + DL |
| 30 | breast carcinoma by gene expression profile | KG + DL |
| 31 | brachydactyly-syndactyly syndrome | KG + DL |
| 32 | Prinzmetal angina | KG + DL |
| 33 | melanoma | KG + DL |
| 34 | dermatofibrosarcoma protuberans | KG + DL |
| 35 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 36 | epithelioid cell uveal melanoma | KG + DL |
| 37 | hyperthyroxinemia | KG + DL |
| 38 | CMM7 | KG + DL |
| 39 | pediatric leptomeningeal melanoma | KG + DL |
| 40 | AIDS | KG + DL |
| 41 | relapsing-remitting multiple sclerosis | KG + DL |
| 42 | obsolete familial combined hyperlipidemia | KG + DL |
| 43 | arteriosclerosis disorder | KG + DL |
| 44 | vulvar melanoma (disease) | KG + DL |
| 45 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 46 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 47 | myelodysplastic syndrome | KG + DL |
| 48 | partial deletion of the long arm of chromosome 5 | KG + DL |
| 49 | plasma cell myeloma | KG + DL |
| 50 | neonatal thyrotoxicosis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.